483 KBI Biopharma Sep 2018

483 KBI Biopharma Sep 2018

Ralph Bernstein FDA, Jamie Dion FDA, Scott Nichols FDA$119.00 - Available Now

FDA investigators audited the KBI Biopharma - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 12 Sep 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Sep 2018
  • Location: Boulder, United States
  • FEI: 3011326133
Add To Cart